T. Toms

发表

Cardiovascular co-morbidity in early rheumatoid arthritis.

H. John, G. Kitas, T. Toms, 2009, Best practice & research. Clinical rheumatology.

Dyslipidaemia in rheumatoid arthritis: the role of inflammation, drugs, lifestyle and genetic factors.

D. Symmons, G. Kitas, T. Toms, 2009, Current vascular pharmacology.

Target organ damage in patients with rheumatoid arthritis: the role of blood pressure and heart rate.

H. John, G. Kitas, T. Toms, 2010, Atherosclerosis.

Prevalence of risk factors for statin-induced myopathy in rheumatoid arthritis patients.

G. Kitas, T. Toms, A. Saratzis, 2010, Musculoskeletal care.

Disease activity and low physical activity associate with number of hospital admissions and length of hospitalisation in patients with rheumatoid arthritis

A. Nevill, G. Kitas, T. Toms, 2011, Arthritis research & therapy.

University of Birmingham Cardiovascular risk factors in women with primary Sjögren's syndrome

B. Griffiths, T. Toms, S. Bowman, 2015 .

Cardiovascular risk factors in women with primary Sjögren ' s syndrome

R. Moots, D. Isenberg, B. Griffiths, 2015 .

The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases.

G. Kitas, T. Toms, D. Mikhailidis, 2010, Current vascular pharmacology.

Rheumatoid cachexia and cardiovascular disease.

A. Nevill, T. Toms, A. Stavropoulos-Kalinoglou, 2009, Clinical and experimental rheumatology.

Anti-TNFα therapy may lead to blood pressure reductions through improved endothelium-dependent microvascular function in patients with rheumatoid arthritis

D. Carroll, G. Kitas, T. Toms, 2011, Journal of Human Hypertension.

Short-term effects of rituximab on flow-mediated dilatation may be mediated by intravenous glucocorticoids: comment on the article by Gonzalez-Juanatey et al.

D. Carroll, G. Kitas, T. Toms, 2009, Arthritis and rheumatism.

Apolipoprotein E Gene Polymorphisms Are Strong Predictors of Inflammation and Dyslipidemia in Rheumatoid Arthritis

G. Kitas, T. Toms, V. Panoulas, 2012, The Journal of Rheumatology.

Dyslipidaemia in Rheumatological Autoimmune Diseases

G. Kitas, T. Toms, V. Panoulas, 2011, The open cardiovascular medicine journal.

Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis.

G. Kitas, T. Toms, P. Taffé, 2008, Endothelium : journal of endothelial cell research.

Dyslipidaemia in Rheumatoid Arthritis

T. Toms, 2012 .

Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors

G. Kitas, T. Toms, J. Hodson, 2013, Clinical Rheumatology.

Are Lipid Ratios Less Susceptible to Change With Systemic Inflammation Than Individual Lipid Components in Patients With Rheumatoid Arthritis?

D. Symmons, G. Kitas, T. Toms, 2011, Angiology.

Lack of association between glucocorticoid use and presence of the metabolic syndrome in patients with rheumatoid arthritis: a cross-sectional study

G. Kitas, T. Toms, H. Griffiths, 2008, Arthritis research & therapy.

Association of mean platelet volume with hypertension in rheumatoid arthritis.

G. Kitas, T. Toms, A. Stavropoulos-Kalinoglou, 2010, Inflammation & allergy drug targets.

Rheumatoid arthritis: is it a coronary heart disease equivalent?

H. John, G. Kitas, T. Toms, 2011, Current opinion in cardiology.

Lymphotoxin 252A>G polymorphism is common and associates with myocardial infarction in patients with rheumatoid arthritis

Peter Nightingale, George D. Kitas, Haralampos J. Milionis, 2008, Annals of the rheumatic diseases.

Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden.

G. Kitas, T. Toms, A. Stavropoulos-Kalinoglou, 2014, Rheumatology.

Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis

G. Kitas, T. Toms, A. Stavropoulos-Kalinoglou, 2011, Annals of the rheumatic diseases.

Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk?

D. Symmons, G. Kitas, T. Toms, 2009, Annals of the rheumatic diseases.

Prediction of cardiovascular risk in rheumatoid arthritis: performance of original and adapted SCORE algorithms

G. Kitas, T. Toms, P. V. van Riel, 2015, Annals of the rheumatic diseases.

Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot Study

D. Carroll, G. Kitas, T. Toms, 2012, BMC Musculoskeletal Disorders.

Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study

H. John, G. Kitas, T. Toms, 2009, Arthritis research & therapy.

Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis

G. Kitas, T. Toms, P. V. van Riel, 2014, Annals of the rheumatic diseases.

Clinical remission following treatment with tumour necrosis factor-alpha antagonists is not accompanied by changes in asymmetric dimethylarginine in patients with rheumatoid arthritis.

G. Kitas, T. Toms, J. Hodson, 2012, Clinical Biochemistry.

Cardiovascular Risk Factors in Women With Primary Sjögren's Syndrome: United Kingdom Primary Sjögren's Syndrome Registry Results

R. Moots, D. Isenberg, B. Griffiths, 2014, Arthritis care & research.

Vascular Function and Inflammation in Rheumatoid Arthritis: the Role of Physical Activity

H. John, G. Kitas, T. Toms, 2010, The open cardiovascular medicine journal.

Cardiovascular risk factors and not disease activity, severity or therapy associate with renal dysfunction in patients with rheumatoid arthritis

H. John, T. Toms, P. Nightingale, 2009, Annals of the rheumatic diseases.

Uric acid is a strong independent predictor of renal dysfunction in patients with rheumatoid arthritis

H. John, G. Kitas, T. Toms, 2009, Arthritis research & therapy.

Microalbuminuria in rheumatoid arthritis in the post penicillamine/gold era: association with hypertension, but not therapy or inflammation

H. John, G. Kitas, T. Toms, 2011, Clinical Rheumatology.

Are Lipid Ratios Less Susceptible to Change With Systemic Inflammation Than Individual Lipid Components in Patients With Rheumatoid Arthritis?

D. Symmons, G. Kitas, T. Toms, 2011, Angiology.

BHPR: Audit and Clinical Evaluation103. Dental Health in Children and Young Adults with Inflammatory Arthritis: Access to Dental Care

T. Spector, D. Lawlor, D. Ray, 2013 .